MedTrace Logo

Safety of Remifentanil Infusion

NCT01303627 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2012-06-25

Study results available
· View outcomes & findings →

Summary

The effect of maintenance remifentanil infusion with target controlled infusion during laryngeal mask airway removal on hemodynamic parameters and emergence quality is going to be investigated.

Conditions

  • Urinary Tract Problem

Interventions

DRUG

remifentanil

1-4 ng/mL i.v. infusion during the surgery, maintenance dosage till LMA removal is 1.5 ng/mL.

Sponsors & Collaborators

  • Diskapi Teaching and Research Hospital

    lead OTHER

Principal Investigators

  • Jülide Ergil, MD · Ministry of Health Dıskapi Yildirim Beyazit Training and Research Hospital, Anesthesiology 1.

  • Alp Alptekin, MD · Ministry of Health Diskapi Yildirim Beyazit Training and Research Hospital, Anesthesiology 1

  • Nihan Aktürk, MD · Ministry of Health Diskapi Yildirim Beyazit Training and Research Hospital , Anesthesiology 1

  • Haluk Gümüs, MD · Ministry of Health Diskapi Yildirim Beyazit Training and Research Hospital, Anesthesiology 1

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2011-03-31
Completion
2011-04-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01303627 on ClinicalTrials.gov